Skip to main content
SpringerLink
Log in

Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. Published online December 21, 2015

  2. Dember LM (2006) Amyloidosis-associated kidney diseases. J Am Soc Nephrol 17:34583471

    Article  Google Scholar 

  3. Sawinski D, Lim MA, Cohen JB, Locke JE, Weiss B, Hogan JJ, Dember LM (2018) Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis. Transplantation. 102(2):300–309

    Article  Google Scholar 

  4. Tandon N, Sidana S, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Fonder AL, Hobbs MA, Hayman SR, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, Go RS, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Kumar SK (2017) Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis. Am J Hematol 92(6):549–554

    Article  CAS  Google Scholar 

  5. Nuvolone M, Merlini G (2017) Systemic amyloidosis: novel therapies and role of biomarkers. Nephrol Dial Transplant 32:770–780

    CAS  PubMed  Google Scholar 

  6. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M (2011) Outcome of AL amyloidosis after highdose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 118(16):4346–4352

    Article  CAS  Google Scholar 

  7. Herrmann SM, Gertz MA, Stegall MD et al (2011) Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant 26:2032–2036

    Article  Google Scholar 

  8. Angel-Korman A, Stern L, Sarosiek S, Sloan JM, Doros G, Sanchorawala V, Havasi A (2019) Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int 95:405–411

    Article  Google Scholar 

  9. Sathick I, Rosenbaum CA, Gutgarts V, Landau H (2020 Feb) Kidney transplantation in AL amyloidosis: is it time to maximize access? Br J Haematol 188(3):e1–e4

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Renal Transplantation, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clinic-Universitat de Barcelona, Barcelona, Spain

    Elena Guillen, Enrique Montagud-Marrahi, Diana M. Rodriguez, Evelyn Hermida, Raul A. Padilla, Miquel Blasco, J. M. Campistol & Luis F. Quintana

  2. Department of Internal Medicine, Hospital Angeles-Clinica Londres, Mexico City, Mexico

    Raul A. Padilla

  3. Department of Hematology, Amyloidosis and Myeloma Unit, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain

    M. Teresa Cibeira & Carlos Fernandez de Larrea

  4. Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    Rodrigo Martino

Authors
  1. Elena Guillen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enrique Montagud-Marrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana M. Rodriguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Evelyn Hermida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raul A. Padilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Miquel Blasco
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Teresa Cibeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rodrigo Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Carlos Fernandez de Larrea
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. M. Campistol
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Luis F. Quintana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Guillen.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guillen, E., Montagud-Marrahi, E., Rodriguez, D.M. et al. Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL). Ann Hematol 99, 2961–2962 (2020). https://doi.org/10.1007/s00277-020-04230-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04230-z

Search

Navigation